Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Adipose-derived mesenchymal stem cell-conditioned medium promotes corneal epithelial cell wound healing in vitro through cell-cycle activation.

Okumura Y., Morooka Y., Sung J., Midorikawa-Inomata A., Fujimoto K., Miura M.

Laboratory Study on Chronic Wound, published in Exp Eye Res (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Exp Eye Res (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
42173433
DOI
10.1016/j.exer.2026.111079

Abstract (original English)

Adipose-derived mesenchymal stem cell-conditioned medium (ADSC-CM) shows potential for promoting corneal epithelial wound healing; however, its effects on human corneal epithelium and underlying mechanisms remain unclear. This study aimed to evaluate the efficacy and mechanism of action of ADSC-CM in corneal epithelial wound healing. Growth factor levels (epidermal growth factor, transforming growth factor beta 1 [TGF-β1], and fibronectin) in ADSC-CM and platelet-rich plasma (PRP) were measured using enzyme-linked immunosorbent assay. The effects of 10% ADSC-CM, PRP, and phosphate-buffered saline on corneal epithelial wound healing were assessed in human corneal epithelial cells, whereas angiogenic effects were evaluated in human umbilical vein endothelial cells. The mRNA expression levels of proliferation, angiogenesis, lymphangiogenesis, and inflammation markers were analyzed using RT-qPCR. RNA sequencing and subsequent Gene Ontology (GO) enrichment analysis and Gene Set Enrichment Analysis (GSEA) were performed to identify differentially expressed genes and enriched pathways. ADSC-CM showed higher epidermal growth factor but lower TGF-β1 and fibronectin levels than PRP and significantly promoted corneal epithelial wound healing compared with PRP and phosphate-buffered saline. ADSC-CM also suppressed human umbilical vein endothelial cell migration. RT-qPCR showed increased ex

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansWound HealingMesenchymal Stem CellsCulture Media, ConditionedEpithelium, CornealAdipose TissueCells, CulturedEnzyme-Linked Immunosorbent AssayCell CycleCell Proliferation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research